Two main previous reviews have extensively depicted the role of ZNF217 in carcinogenesis by affecting the hallmarks of cancers (for review [1,2]), emphasizing ZNF217 importance as a prognostic biomarker for early prevention and as a therapeutic target. The gene discussed is ZNF217; the disease is cancer.